For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

The House Republicans’ budget blueprint, blessed by Speaker Mike Johnson, has long been stalled in the chamber. On Tuesday, Arrington called for a Thursday committee meeting to resolve vast ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

Cleveland Clinic experts reveals what's behind "Ozempic face," and list the semaglutide-associated symptoms that can call for ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease, Novo Nordisk said.

Ozempic, which the US Food and Drug Administration has approved to treat diabetes, and Wegovy, which is approved for weight loss and the prevention of heart attacks and strokes, are wildly popular.